Skip to main content

Year: 2025

Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Presented preclinical data for JADE101 at the 62nd European Renal Association Congress, highlighting its potential as a best-in-class anti-APRIL monoclonal antibody for IgA nephropathyPhase 1 healthy-volunteer study of JADE101 expected to begin in the third quarter of 2025, with interim, biomarker-rich data anticipated in the first half of 2026$220.9 million cash and cash equivalents as of June 30, 2025 supports cash runway through 2027, including multiple clinical inflection pointsSAN FRANCISCO and VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) — Jade Biosciences, Inc. (“Jade”) (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced financial results for the quarter ending June 30, 2025, and provided a corporate update. “We’ve had a productive...

Continue reading

Expion360 Reports Second Quarter 2025 Financial and Operational Results

Q2 2025 Sales Growth of 134% to $3.0 Million Fueled by Strong Demand for New Products and Technologies Records Two of the Most Successful Months of Sales in Company History in Q2 2025 Sixth Consecutive Quarter of Sales Growth REDMOND, Ore., Aug. 13, 2025 (GLOBE NEWSWIRE) — Expion360 Inc. (Nasdaq: XPON) (“Expion360” or the “Company”), an industry leader in lithium iron phosphate battery power storage, today reported its financial and operational results for the first quarter ended June 30, 2025. Second Quarter 2025 and Subsequent Financial and Operational HighlightsQ2 2025 net sales totaled $3.0 million, up 134% from Q2 2024, and up 46% from Q1 2025. First half 2025 net sales of $5.0 million, up 124% from the first half of 2024. 6th consecutive quarter of sales growth. Gross profit increased 91% compared to Q2 2024. First half...

Continue reading

Aqua Metals Advances Commercialization of AquaRefining™ Technology with Industry-Leading Lithium Quality and Strategic Progress During Second Quarter of 2025

Company eliminates long-term debt, strengthens balance sheet, and extends cash runway through asset sales and cost-reduction initiatives RENO, Nev., Aug. 13, 2025 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or the “Company”), a pioneer in sustainable metals recycling, today announced financial results and operational highlights for the quarter ended June 30, 2025. The Company achieved significant progress toward commercialization, delivering best-in-class product quality, advancing key strategic initiatives, and fortifying its financial position. Second Quarter and Recent Highlights: Operational InitiativesProduced Industry-Leading Low-Fluorine Lithium Carbonate: Reduced fluorine content in lithium carbonate to less than 30 parts per million (ppm), a likely best-in-class achievement in the global recycling...

Continue reading

Coherent Announces Agreement to Sell Aerospace and Defense Business to Advent for $400 Million

SAXONBURG, Pa., Aug. 13, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR) (“Coherent,” “We,” or the “Company”), a global leader in photonics, today announced that it has entered into a definitive agreement to sell its Aerospace and Defense business to Advent, a leading global private equity investor, for $400 million. Proceeds will be used to reduce debt, which will be immediately accretive to Coherent’s EPS. Coherent’s Aerospace and Defense designs and manufactures optical and laser systems for defense applications. The business includes approximately 550 employees and 10 geographic sites. “We are pleased to have reached this agreement with Advent. As part of our strategic portfolio optimization process, this transaction furthers our strategy to concentrate efforts on core growth markets and products,” said Jim Anderson, CEO...

Continue reading

Repeat – Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology

Tevogen.AI to explore external market opportunities as a potential revenue source. Beta version to incorporate oncology targets, enhancing the accuracy and diversity of the PredicTcell model and potentially accelerating cancer immunotherapy development. Tevogen.AI to develop enhanced analytics and visualization tools, for the PredicTcell model to support its internal R&D teams.WARREN, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that its artificial intelligence initiative, Tevogen.AI, is expanding its collaboration with Microsoft (Nasdaq: MSFT) and Databricks, to build the beta version of its foundational PredicTcell model. Powered by the Databricks Data Intelligence Platform and backed by their innovative engineering teams, Tevogen.AI has begun...

Continue reading

Emerita Announces Upsize to C$25M Brokered Private Placement Financing

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) — Emerita Resources Corp. (“Emerita” or the “Company”) (TSXV:EMO) (OTCQB:EMOTF) (FSE:LLJA) is pleased to announce that, due to strong investor demand, it has agreed with Clarus Securities Inc. and Velocity Trade Canada as co-lead agents on behalf of a syndicate of agents (collectively, the “Agents”), to increase the size of its previously announced $15,000,090 best-efforts marketed private placement (the “Offering”). Pursuant to the upsized deal terms, the Offering will now consist of up to 23,809,500 units of the Company (the “Units”) at a price of $1.05 per Unit (the “Issue Price”) for gross proceeds to the Company...

Continue reading

Pinnacle Bankshares Corporation Announces Increased Dividend

ALTAVISTA, Va., Aug. 13, 2025 (GLOBE NEWSWIRE) — Pinnacle Bankshares Corporation (“Pinnacle” or the “Company”) (OTCQX: PPBN), the one-bank holding company for First National Bank (the “Bank”), announced today that its Board of Directors declared a cash dividend of $0.27 per share on August 12, 2025, payable September 5, 2025, to shareholders of record as of August 22, 2025. The $0.27 per share cash dividend is an increase of $0.01, or 4%, as compared to the $0.26 paid last quarter and marks the second increase this year and fifty-second consecutive quarter that a dividend has been declared. “We are pleased to further increase Pinnacle’s cash dividend to $0.27 per share,” stated Aubrey H. Hall, III, President and Chief Executive Officer for both the Company and the Bank. Mr. Hall further commented, “This return on investment is...

Continue reading

Toll Brothers Announces New Luxury Home Community Coming Soon to Briggs Ranch in San Antonio, Texas

SAN ANTONIO, Aug. 13, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Toll Brothers at Briggs Ranch, is coming soon to San Antonio, Texas. This exclusive Toll Brothers neighborhood will include modern single-family homes on spacious 50-foot-wide home sites within the sought-after Briggs Ranch master plan. Site work is underway, and the community is anticipated to open for sale in fall 2025. Toll Brothers at Briggs Ranch offers a selection of dynamic one- and two-story floor plans ranging from 1,913 to 3,116 square feet with open-concept spaces and outdoor living opportunities. Home shoppers can choose from six distinct home designs with 3 to 5 bedrooms, 2 to 4.5 baths, and 2-car garages, with anticipated pricing from the mid-$400,000s. Each...

Continue reading

ScanTech AI Announces Development of Next-Generation Enhancements for the SENTINEL® CT System

Atlanta, GA, Aug. 13, 2025 (GLOBE NEWSWIRE) — ScanTech AI Systems Inc. (the “Company” or “ScanTech AI”) (Nasdaq: STAI), a next-generation provider of AI-powered CT screening systems for aviation, customs, and critical infrastructure, is thrilled to announce the development of its upcoming AI-powered software, a groundbreaking upgrade exclusively for the SENTINEL CT Computed Tomography. The next generation AI upgrade represents a bold leap forward in checkpoint operations, combining modern AI-powered intelligence, lightning-fast performance, and a sleek, intuitive interface. Designed to enhance both operator experience and throughput, this upcoming upgrade delivers real-time insights and unprecedented flexibility, positioning SENTINEL as one of the most advanced CT screening solutions on the market. “This...

Continue reading

SCOR: The timeline of the 2022 arbitration relating to retrocession treaties remains unchanged

Press release13 August 2025 – N° 13    The timeline of the 2022 arbitration relating to retrocession treaties remains unchanged    In 2022, SCOR filed an arbitration seeking the execution of the retrocession treaties signed with Covéa in June 2021. At the end of July 2025, Covéa requested that the tribunal in charge of this dispute stay its proceedings and SCOR opposed this request (see our communication dated 31 July 2025 for more details).  SCOR reports that the arbitration tribunal has decided to maintain the original timeline of these proceedings, with a final decision expected during the course of 2026.   All major arbitrations and disputes in which SCOR is involved are provisioned at best estimate in SCOR’s audited financial statements.   This update completes the ad hoc disclosure published on 31 July 2025 pursuant to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.